Indeed, DLK1 vaccination also promoted enhanced deposits of Type-1 skewed CD8+ T cells that likely contributed to durable anti-tumor responses through epitope spreading in a majority of mice (see Figure 3E). This evidence concerns the gene DLK1 and neoplasm.